​

CDT Equity Stock (NASDAQ:CDT)

RevenueOwnershipFinancialsChart
CDT Equity by TradingView

Previous Close

$1.81

52W Range

$1.48 - $2.20K

50D Avg

$2.92

200D Avg

$33.92

Market Cap

$2.35M

Avg Vol (3M)

$779.47K

Beta

1.75

Div Yield

-

CDT Company Profile

CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

6

IPO Date

Mar 28, 2022

Website

CDT Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 24
Automation Solutions$1.32B

Fiscal year ends in Dec 24 | Currency in USD

CDT Financial Summary

Dec 24Dec 23Dec 22
Revenue$2.46B--
Operating Income$266.46M$-5.56M$-3.16M
Net Income$198.43M$-535.00K$-4.89M
EBITDA$266.46M$-324.00K$-1.43M
Basic EPS$4.88$-0.18$-0.56
Diluted EPS$4.80$-0.18$-0.56

Fiscal year ends in Dec 24 | Currency in USD

Peer Comparison

TickerCompany
XAGELongevity Health Holdings Inc.
COCHEnvoy Medical, Inc.
ZVSAZyVersa Therapeutics, Inc.
WORXSCWorx Corp.
LIXTLixte Biotechnology Holdings, Inc.
PTPIPetros Pharmaceuticals, Inc.
CCMConcord Medical Services Holdings Limited
NIVFNewGenIvf Group Limited
ENVBEnveric Biosciences, Inc.